Yahoo Finance 4 Marijuana Stocks Seeing New Highs On Wednesday (1/30/19)
CORAL GABLES, FL / ACCESSWIRE / January 30, 2019 / The 2018 year for the marijuana stock market was instrumental in surmounting much its stability throughout the market, whereas other industries suffered from bouts with market volatility. Though we've only seen a month of 2019, the new year has shown a significant amount of bullish sentiment among investors in the cannabis industry. Following several monumental pieces of cannabis legislation, the industry has seen a dramatic increase in public opinion, motivating companies in the space to continue to innovate and manufacture new products utilizing the many use cases of marijuana. As we continue to move through this new year, the hopes are that the cannabis industry will be able to see even more gains in the future. Nabis Holdings (INNPF) (NAB), Khiron Life Sciences Corp (KHRNF), Canopy Growth Corp (CGC) (WEED.TO), and Tilray Inc (TLRY) are four cannabis companies focused on improving the quality of life for their consumers.
Nabis Holdings (INNPF) (NAB) is a Company focused on strategically investing in high-quality cash flowing assets across several integral aspects of the cannabis sector primarily in the U.S. limited license states with plans to expand to global markets in the near-future. In terms of the Company's corporate strategy, Nabis' framework was born from a desire to allow the company to enable identifying and acquiring majority interests in high-quality cash-flowing U.S. cannabis assets and brands in Limited License States at fair-market prices.
Earlier this week, Nabis Holdings (INNPF) (NAB) announced that the Company had entered into a binding letter of intent to invest in a 70% interest of Hivemind Refinery, an established wellness product line of CBD-based wellness products in the United States. Per the details of the announcement, the investment into HIVEMIND expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum and will fall under the Company's lifestyle brand.
In more recent news, Nabis Holdings (INNPF) (NAB) announced yesterday that the Company has entered into a binding term sheet to acquire 100% of the membership units of Organica Patient Group Inc, and RDF Management Group in the State of Arizona, USA. Following the announcement of the term sheet agreement, Shay Shnet, CEO and Director of Nabis, said, ''we are very excited to be working with OPG and will continue to identify accretive investment opportunities in Arizona along with other key limited license states in the coming months.''
For More Information On Nabis Holdings, Click Here
Khiron Life Sciences Corp (KHRNF) saw impressive gains in the market on Wednesday, with shares soaring to nearly 18%, trading at $1.75 per share. The Company today announced that it has signed a binding letter of intent to establish a 50/50 joint venture with Dixie Brands Inc to introduce a full line of cannabis-infused products to the Latin American market. Per the details of the announcement, Dixie will also manufacture and distribute Khiron's Kuida® brand of cannabidiol (CBD)-based cosmeceuticals in the United States, targeting the growing Hispanic population.
Alvaro Torres, Co-founder and CEO of Khiron Life Sciences, stated, ''this joint venture is a combination of two companies coming together to bring great brands with highly complementary products, distribution capabilities and expertise.''
For More Information On Khiron Life Sciences Corp, Click Here
Canopy Growth Corporation (CGC) (WEED) enjoyed a solid 4.16% boost in early-afternoon trading on Wednesday, with shares trading just above $49.10 per share. The Company's market performance may be connected to ongoing excitement surrounding an announcement for earlier this month detailing the Company's progress in European cannabis markets. The Company's medically focused business Spectrum Cannabis has continued to build a pan-European cannabis production and distribution network across the UK and Poland.
Dr. Mark Ware, Chief Medical Officer for Canopy Growth, said in regards to Spectrum UK that it ''has the expertise and ambition to simplify the UK medicinal cannabis landscape and ensure access to cannabis-based medicinal products for patients with great clinical unmet need.''
For More Information On Canopy Growth Corp, Click Here
Tilray Inc (TLRY) found itself in headlines earlier this month when the Company announced that it had entered into a definitive agreement pursuant to which Tilray, through a wholly-owned subsidiary, will acquire all of the issued and outstanding securities of Natura Naturals Holdings Inc., the parent company of a licensed cultivator of cannabis. As a result of the acquisition, if completed, Tilray will obtain Natura's 662,000 square-foot greenhouse cultivation facility, of which 155,000 square-feet are currently licensed, and all subsequent cannabis output from this facility.
In a press release regarding the agreement, Tilray will deliver C$35 million at closing, comprised of C$15 million in cash and C$20 million in Tilray Class 2 common stock. Natura shareholders will receive their pro rata portion of the C$15 million closing cash amount, after the deduction of certain transaction expenses incurred by Natura and subject to applicable withholding taxes. Upon Natura reaching certain quarterly production milestones over the following twelve-month period, up to C$35 million of Tilray common stock may become payable resulting in a total purchase price of C$70 million if fully achieved.
For More Information On Tilray Inc, Click Here
About marijuanastocks.com
MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana-related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. MAPH Enterprises LLC which owns www.MarijuanaStocks.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.
MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. MAPH Enterprises LLC, which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Nabis Holdings (OTC:INNPF) (CSE:NAB), Midam has been paid $250,000 by Nabis Holdings (OTC:INNPF) (CSE:NAB) for a period from January 22, 2019 to April 22, 2019. We may buy or sell additional shares of (OTC:INNPF) (CSE:NAB) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Nabis Holdings (OTC:INNPF) (CSE:NAB). Click here for our full disclaimer.
Contact Information:
SOURCE: MarijuanaStocks.com
